Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its lead oral drug candidate for a potentially curative treatment of HBV infections.
Location: South Africa, North West, Atlanta
Employees: 1-10
Total raised: $196M
Founded date: 2018
Investors 10
Funding Rounds 3
| Date | Series | Amount | Investors |
| 03.11.2021 | Series B | $75M | - |
| 13.04.2021 | Series B | $96M | - |
| 27.11.2018 | Series A | $25M | - |
Mentions in press and media 21
| Date | Title | Description | Source |
| 04.11.2021 | Google Cloud goes deep into financial services with $1 billi... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 04.11.2021 | Google Cloud goes deep into financial services with $1 billi... | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 03.11.2021 | Antios Therapeutics Raises $75 Million in a Series B-1 Fundi... | MENDHAM, NJ – November 03, 2021 — Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmace... | aislingcap... |
| 03.11.2021 | Antios, months after series B, raises a further $75M to fuel... | Antios Therapeutics is going full throttle in pursuit of a curative hepatitis B therapy, raising $75... | fiercebiot... |
| 03.11.2021 | Antios Therapeutics Raises $75 Million in a Series B-1 Fundi... | MENDHAM, N.J. /PRNewswire/ — Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmaceutica... | avego.com/... |
| 03.11.2021 | Antios Therapeutics Raises $75 Million in a Series B-1 Fundi... | MENDHAM, N.J., Nov. 3, 2021 /PRNewswire/ -- Antios Therapeutics, Inc. ("Antios"), a clinic... | marketscre... |
| 03.11.2021 | Antios, months after series B, raises a further $75M to fuel... | Antios Therapeutics is going full throttle in pursuit of a curative hepatitis B therapy, raising $75... | fiercebiot... |
| 03.11.2021 | Antios Therapeutics Raises $75 Million in a Series B-1 Fundi... | Antios Therapeutics, Inc. (“Antios”), a clinical-stage biopharmaceutical company developing innovati... | lumiravent... |
| 03.11.2021 | Antios Therapeutics Raises $75 Million in a Series B-1 Fundi... | - | amzakhealt... |
| 13.04.2021 | Antios Therapeutics Raises $96M in a Series B | ATLANTA, GA, Antios Therapeutics announced the successful completion of a $96 million Series B fin... | vcnewsdail... |
Show more